IRIS - Res&Arch Institutional Research Information System - Research & Archive

ANGELI, FABIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.629
EU - Europa 1.261
AS - Asia 1.152
SA - Sud America 207
AF - Africa 13
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.270
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.599
SG - Singapore 545
IE - Irlanda 254
UA - Ucraina 214
HK - Hong Kong 194
IT - Italia 189
SE - Svezia 182
BR - Brasile 177
VN - Vietnam 160
CN - Cina 156
RU - Federazione Russa 144
FI - Finlandia 86
DE - Germania 77
GB - Regno Unito 31
KR - Corea 22
CA - Canada 16
FR - Francia 16
TR - Turchia 15
AT - Austria 13
AR - Argentina 12
IN - India 11
CH - Svizzera 10
IQ - Iraq 9
BD - Bangladesh 8
NL - Olanda 8
UZ - Uzbekistan 8
MX - Messico 7
PK - Pakistan 7
BE - Belgio 6
PL - Polonia 6
ZA - Sudafrica 6
EC - Ecuador 5
ES - Italia 4
ID - Indonesia 4
JP - Giappone 4
NZ - Nuova Zelanda 4
VE - Venezuela 4
GR - Grecia 3
LT - Lituania 3
PY - Paraguay 3
AU - Australia 2
BG - Bulgaria 2
BY - Bielorussia 2
CL - Cile 2
CZ - Repubblica Ceca 2
EE - Estonia 2
KZ - Kazakistan 2
LB - Libano 2
ME - Montenegro 2
PE - Perù 2
TN - Tunisia 2
UG - Uganda 2
AE - Emirati Arabi Uniti 1
BB - Barbados 1
CO - Colombia 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EU - Europa 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
JM - Giamaica 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MA - Marocco 1
NR - Nauru 1
RO - Romania 1
RS - Serbia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 4.270
Salva come PNG Salva come JPEG
Città #
Singapore 355
Chandler 295
Dublin 254
Hong Kong 193
San Mateo 140
Jacksonville 136
Dong Ket 107
Altamura 91
Boardman 90
Santa Clara 75
Ashburn 71
Medford 69
Princeton 69
Lawrence 67
Beijing 57
Wilmington 57
Perugia 48
Moscow 37
Ann Arbor 24
Helsinki 23
New York 22
Seoul 22
Andover 21
Los Angeles 18
São Paulo 18
Ho Chi Minh City 17
Hanoi 16
Saint Petersburg 16
Des Moines 15
Norwalk 11
Izmir 10
Falls Church 9
Munich 9
San Paolo di Civitate 9
Brooklyn 8
Redwood City 8
Shanghai 8
Atlanta 7
Brussels 6
Chicago 6
Denver 6
Rio de Janeiro 6
Rome 6
Woodbridge 6
Amsterdam 5
Belo Horizonte 5
Chennai 5
Columbus 5
Council Bluffs 5
Johannesburg 5
London 5
Montreal 5
Phoenix 5
Porto Alegre 5
Toronto 5
Vienna 5
Amelia 4
Baghdad 4
Caxias do Sul 4
Mexico City 4
Nuremberg 4
San Francisco 4
Seattle 4
Tokyo 4
Warsaw 4
Bauru 3
Cagliari 3
Falkenstein 3
Goiânia 3
Houston 3
Kaifeng 3
Lahore 3
Manchester 3
Ottawa 3
Piscataway 3
Redmond 3
Ribeirão Preto 3
Salvador 3
San Diego 3
Tashkent 3
Turku 3
Almaty 2
Ankara 2
Aracaju 2
Asunción 2
Auckland 2
Bandung 2
Biên Hòa 2
Campos do Jordão 2
Caracas 2
Curitiba 2
Den Haag 2
Dhaka 2
Fortaleza 2
Guayaquil 2
Karachi 2
Lima 2
L’Aquila 2
Manaus 2
Miami 2
Totale 2.720
Salva come PNG Salva come JPEG
Nome #
Beta-blockers and risk of all-cause mortality in non-cardiac surgery. 95
Aliskiren versus ramipril in hypertension. 91
Adverse prognostic significance of new diabetes in treated hypertensive subjects 90
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials. 90
New-onset diabetes, antihypertensive treatment, and outcome 89
Improved cardiovascular risk stratification by a simple ECG index in hypertension 87
Above which blood pressure level does the risk of atrial fibrillation increase? 86
Prehypertension and Cardiometabolic Syndrome 84
Angiotensin-converting enzyme inhibitors 83
Meta-Analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension 82
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension: Prognostic Implications 80
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke. 78
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension 77
Optimal therapy in hypertensive subjects with diabetes mellitus 77
Microalbuminuria and hypertension. 76
Angiotensin receptor blockers in hypertension. New insights from Japan. 75
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus. 75
Betabloccanti e ipertensione arteriosa. Evidence-based medicine o eccessivo accanimento? 75
Optimizing the definition of dippers and nondippers: is a 70-86% full glass empty? 74
Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients 74
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain 74
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis. 73
Blood pressure lowering in diabetic patients. 73
Lowering blood pressure with β-blockers in peripheral artery disease: the importance of comorbidity 71
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study 70
Home Blood Pressure Measurements Will Not Replace 24-Hour Ambulatory Blood Pressure Monitoring. 69
Modernization and hypertension: is the link changing? 69
Atrial fibrillation and mortality in patients with acute myocardial infarction: a systematic overview and meta-analysis. 69
Quali novità nella gestione dell’ipertensione arteriosa dopo le recenti linee guida europee e nordamericane? 69
Usual versus tight control of systolic blood pressure in non-diabetic patients with hypertension (Cardio-Sis): an open-label randomised trial. 68
Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers. 67
New-onset diabetes in treated hypertensive patients 67
Validation of the A&D UA-774 (UA-767Plus) device for self-measurement of blood pressure. 66
Home Blood Pressure Measurements Will or Will Not Replace 24-Hour Ambulatory Blood Pressure Measurement. 65
Risk Prediction Models for Hypertensive Disorders of Pregnancy: Role of 12-Lead Electrocardiography 65
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment. 64
Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention 64
Comparative assessment of angiotensin receptor blockers in different clinical settings. 63
Tight blood pressure control in diabetes: evidence-based review of treatment targets in patients with diabetes. 62
Finding a place for aliskiren in the wide spectrum of blood pressure lowering agents. 60
Modern treatment of patients at risk: stilla HOPE for ACE inhibitors? 57
Diuretic treatment of hypertension 57
Perioperative beta blockade: the debate continues. 56
"From apennines to andes:" does body mass index affect the relationship between age and blood pressure? 56
Hypertrophy at ECG and its regression during treatment survey (HEART survey). Rationale, design and baseline characteristics of patients. 54
Telmisartan for the reduction of cardiovascular morbidity and mortality. 52
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions. 52
Statins in acute coronary syndrome: very early initiation and benefits. 50
Short- and Long-Term Incidence of Stroke in White-Coat Hypertension 49
White-coat hypertension in adults. 48
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives 48
Multivariable analysis in cerebrovascular research: practical notes for the clinician. 47
Neutrophil count and ambulatory pulse pressure as predictors of cardiovascularadverse events in postmenopausal women with hypertension 47
Hypertension around the world: new insights from developing countries. 46
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy. 46
Good news for beta-blockers in perioperative medicine. 45
Role and prognostic value of individual ambulatory blood pressure components in chronic kidney disease 45
More than a REASON to use arterial stiffness as risk marker and therapeutic target in hypertension 44
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome. 44
Hypertension and the J-curve phenomenon: implications for tight blood pressure control 42
Mecanismos de la hipertrofia ventricular izquierda en la hipertensión: Más que solo la presión arterial 42
Protein intake in type 1 diabetes: putting controversies into perspectives. 42
Prognostic value of lipoprotein fractions in essential hypertension. 41
II monitoraggio ambulatoriale della pressione arteriosa nella pratica clinica 41
Pharmacokinetic evaluation and clinical utility of azilsartan medoxomil for the treatment of hypertension. 41
What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg? 41
Is hydrochlorothiazide more effective on LVH in nonresponders to losartan than in those to atenolol? 40
Tight Blood Pressure Control Saves Lives in Hypertensive Patients With Chronic Kidney Disease 38
Fixed-dose combination therapy in hypertension: cons. 35
Unattended compared to traditional blood pressure measurement in patients with rheumatoid arthritis: a randomised cross-over study 35
Totale 4.367
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.451
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.451
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021311 0 0 0 0 0 35 39 1 54 21 46 115
2021/2022472 9 86 18 35 11 5 1 167 4 3 61 72
2022/2023969 71 218 8 65 89 87 3 62 310 4 37 15
2023/2024325 24 44 17 5 5 1 58 2 38 10 46 75
2024/2025765 4 76 29 51 105 35 50 34 146 42 151 42
2025/2026819 118 115 120 181 236 49 0 0 0 0 0 0
Totale 4.367